ENTPD1 and neoplasm: CAR-T cells were sequentially co-cultured at 1:2 E:T ratio with Nalm6-GFP ± GD2, tumor growth was assayed using Incucyte, and CD39 and PD-1 were measured by flow cytometry upon tumor clearance (Fig. 8E).